Friedreich Ataxia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are male or female and are 6 years old or older at the time of signing the consent forms
- You have been diagnosed with Friedreich's Ataxia (FA), confirmed by both your symptoms and a genetic test showing the specific gene changes linked to FA, and your symptoms started when you were 25 years old or younger
- You have been confirmed to have thickening of the heart's left pumping chamber (a condition called left ventricular hypertrophy)
- Your heart's left pumping chamber is still working at least 40% of its normal pumping capacity
Who may not be able to join:
- You have another type of heart muscle disease, a significant structural heart problem, significant coronary artery disease, or a serious heart valve problem that is not caused by your FA
- You are currently receiving heart-strengthening medication through a drip (IV), have a mechanical heart pump device, or have previously had a heart transplant
- You have a reason why you cannot have a cardiac MRI scan — though children under 12 who cannot have the scan without being sedated may still qualify and will have an ultrasound of the heart instead (confirm with trial site)
- You have previously had any organ transplant
- You have started a specific heart rhythm treatment called cardiac resynchronization therapy within the past 6 months
- You have previously received gene therapy or cell therapy of any kind
- You have diabetes that is not well controlled, shown by a blood sugar level test result of 8% or higher
- You currently have an active blood cancer or solid organ cancer
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Lexeo Clinical Trials, Lexeo Therapeutics
Phone: 212-547-9879
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Characterize cardiac disease presentation and progression among participants
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.